Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | ADAM17 | P78536 | 4/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | CASP1 | P29466 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | CCR8 | P51685 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23375880 | 0.83 | ALDH1A1 (0.38) | ALDH1A1KDM4EMAPTHTTL3MBTL1 | |
| SCHEMBL23375509 | 0.81 | ALDH1A1 (0.47) | ALDH1A1KDM4EHTTL3MBTL1PKM | |
| SCHEMBL29688152 | 0.81 | ALDH1A1 (0.47) | ALDH1A1KDM4EHTTL3MBTL1PKM | |
| SCHEMBL21439250 | 0.81 | ALDH1A1 (0.47) | ALDH1A1KDM4EHTTL3MBTL1PKM | |
| SCHEMBL29688113 | 0.81 | ALDH1A1 (0.47) | ALDH1A1KDM4EHTTL3MBTL1PKM | |
| SCHEMBL12742334 | 0.67 | L3MBTL1 (0.59) | ALDH1A1L3MBTL1LMNAFFAR1TSHR | |
| SCHEMBL31501110 | 0.66 | L3MBTL1 (0.48) | ALDH1A1HTTL3MBTL1PKMNPSR1 | |
| SCHEMBL23635693 | 0.66 | CYP4F2 (0.64) | ALDH1A1KDM4EMAPTSMN1; SMN2 | |
| SCHEMBL6081939 | 0.66 | LMNA (0.51) | ALDH1A1HTTL3MBTL1LMNAPKM | |
| SCHEMBL1375795 | 0.65 | ALDH1A1 (0.44) | ALDH1A1KDM4EHTTL3MBTL1PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210147343-A1 | OPIOID RECEPTOR MODULATORS AND PRODUCTS AND METHODS RELATED THERETO | EPIODYNE, INC. | 2021-05-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210147343-A1 | OPIOID RECEPTOR MODULATORS AND PRODUCTS AND METHODS RELATED THERETO | OPRM1, OPRD1, OPRK1 | ALDH1A1 1936/4885KDM4E 3124/4885MAPT 1862/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.